News | July 28, 2023
Laurus Labs posts decline in Q1FY24 consolidated PAT to Rs. 24.85 Cr
The company has reported total income of Rs. 1185.39 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1185.39 crores during the period ended June 30, 2023
Dr. Lal Path Labs Ltd. has reported total income of Rs. 555.4 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1052.79 crores during the period ended June 30, 2023
Uses a simple mechanical approach for removing intrauterine tissues
Cipla has reported total income of Rs. 6465.18 crores during the period ended June 30, 2023
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Zurletrectinib was developed to treat advanced or metastatic solid tumors harboring NTRK fusion genes
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
Subscribe To Our Newsletter & Stay Updated
